Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Premier Biosoft Partner on Lipidomics Technologies

NEW YORK (GenomeWeb News) – Agilent Technologies and Premier Biosoft today said they will support the combination of each other's technologies to advance lipidomics research.

Agilent's time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software used in conjunction with Premier's SimLipid 3.3 identification and quantification software will allow scientists to overcome obstacles that have stood in the way of lipid identification and analysis, the firms said.

"Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism," Daniel Kassel, Agilent’s senior director of LC/MS global marketing, said in a statement. "By utilizing this combined network of technologies, researchers can be confident in the analytical strength they have come to expect from Agilent and from the advanced lipid identification capabilities provided in Premier Biosoft’s SimLipid software."
 
Premier CEO Arun Apte added, "Our SimLipid software supports data from Agilent’s well-known MassHunter, Mass Profiler Professional and Pathway Architect software programs, creating an integrated workflow for the accurate and efficient identification and contextualization of lipids on metabolic pathways."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.